See below for details of all PrecisionLife news, events and media activity as well as links to Disease Studies, research, and publications.
Why does chronic disease drug discovery & development need fixing?
The blockbuster model for drug discovery and development in chronic diseases is inefficient and costly. We need a new…
12/10/21
BIA Tech Bio Meet Up
15 December 2021 PrecisionLife, Chief Executive Officer, Dr Steve Gardner, is joining the BIA Tech Bio Meet Up on…
15/12/21
BREATHE Industry Forum
15 December 2021 PrecisionLife, Chief Medical Officer, Dr Veronique Bouchet, is speaking at the BREATHE Industry Forum on 15…
15/12/21
Future of Precision Medicine Symposium
Copenhagen, 22-23 November 2021 Co-founders of PrecisionLife, Chief Executive Officer Steve Gardner, PhD and Chief Analytics Officer Gert L…
22/11/21
BioData World Congress 2021
Basel, 2-4 November 2021 PrecisionLife is attending the BioData World Congress 2021. The event is Europe’s largest congress covering…
22/10/21
BIO Europe 2021
Online, 25-28 October 2021 PrecisionLife is attending the international BIO Europe 2021 gathering alongside global biopharma and investment leaders…
22/10/21
UK BioIndustry Association launches first TechBio company report
OXFORD, UK: PrecisionLife featured as a case study of how a data-driven techbio company is transforming drug discovery and…
15/10/21
BIA Bioscience Forum
London, 14 October 2021 PrecisionLife CEO, Dr Steve Gardner, will join an expert panel at the BIA Bioscience Forum…
6/10/21
WEBINAR: Disease Mechanisms and Target Discovery
PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji in a webinar exploring Disease Mechanisms and Target Discovery….
6/10/21
Anyone for tea? Why Alzheimer’s drug discovery might be targeting the impossible
Unique approach to precision medicine could reverse the trend in Alzheimer’s disease drug discovery and development Clinical trials in…
27/09/21
Neuropsychiatric Drug Development Summit
Online, 29-30 September 2021 Members of the PrecisionLife team will join leaders from the likes of Sunovion, Merck, Takeda,…
24/09/21
Best Chronic Disease Biology Company 2021 awarded to PrecisionLife
OXFORD, UK The International Life Sciences Awards has named PrecisionLife as the Best Chronic Disease Biology R&D Company 2021.
20/09/21
Complexity of disease biology gives opportunities for drug discovery
Late-stage clinical trials incur the biggest costs of bringing new drugs to market. Increasingly clinical trial failures happen late….
1/09/21
Understanding AI and its important role in MND research
“The search for new drugs to help people living with MND is long and challenging, but it is one…
22/07/21
Precision medicine and chronic disease
Chronic diseases, which account for 85% of healthcare costs, still have significant remaining pockets of unmet medical need that…
15/07/21
Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients
The study undertaken by PrecisionLife and Optum Labs leaders Taryn O. Hall and Kathy T.H. Zheng using data from…
8/07/21
Chairman Q&A: from Pepsi to PrecisionLife
A Q&A with PrecisionLife Executive Chairman Ray Pawlicki reflecting on a senior leadership career that moved from Pepsico, to…
24/06/21
Ray Pawlicki, Previously CIO at Biogen and Novartis, Joins PrecisionLife as Executive Chair to Accelerate Strategic Expansion
OXFORD, UK June 24th, 2021 –
24/06/21